Nerve agent attacks on children: diagnosis and management.

Area of Science:

• Toxicology
• Pediatric Emergency Medicine
• Chemical Warfare Agents

Background:

• Nerve agents (NAs) represent a significant chemical weapons threat.
• NA poisoning in children presents unique pathophysiological and clinical challenges compared to adults.
• Understanding these differences is critical for effective medical management.

Purpose of the Study:

• To review the pathophysiology of NA poisoning specifically in children.
• To outline the management strategies for pediatric NA exposure.
• To highlight differences in clinical presentation and treatment considerations for children.

Main Methods:

• Review of existing literature on NA pathophysiology and management in pediatric populations.
• Analysis of clinical manifestations of NA poisoning in children versus adults.
• Evaluation of current and potential antidote therapies and supportive care.

Main Results:

• Children may exhibit distinct signs of cholinergic crisis, often presenting with neurological derangements rather than classic miosis or glandular secretions.
• Effective management includes limiting exposure, respiratory support, and prompt administration of antidotes.
• Autoinjectors are practical for prehospital administration of intramuscular antidotes.
• Key antidotes include anticholinergics (e.g., atropine), oximes (e.g., pralidoxime chloride, with longer half-life in children), and benzodiazepines (e.g., diazepam, midazolam for seizures).

Conclusions:

• Pediatric NA poisoning requires tailored management due to unique clinical presentations.
• Prompt and appropriate administration of specific antidotes and supportive care are vital to mitigate morbidity.
• Further research into optimal anticonvulsant therapies like midazolam for pediatric NA exposure is warranted.